Agoracom Blog Home

Posts Tagged ‘#smallcapstocks’

Namaste Signs Definitive Agreement to Acquire Cannmart Inc. and Announces Conference Call $N.ca

Posted by AGORACOM-JC at 8:16 AM on Monday, April 24th, 2017

Nlogo

  • Signed a definitive agreement  with Cannmart In whereby Namaste will purchase all of the issued and outstanding shares in the capital of CannMart
  • In 2014, CannMart submitted its application to Health Canada to become a “sales only” licensed producer of medical cannabis

VANCOUVER, BRITISH COLUMBIA–(April 24, 2017) -

Namaste Technologies Inc. (“Namaste” or the “Company“) (CSE:N)(CSE:N.CN)(FRANKFURT:M5BQ)(OTCQB:NXTTF) is pleased to announce that it has signed a definitive agreement (the “Agreement“) with Cannmart Inc. (“CannMart“) whereby Namaste will purchase all of the issued and outstanding shares in the capital of CannMart, a late stage applicant under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR“). In 2014, CannMart submitted its application to Health Canada to become a “sales only” licensed producer of medical cannabis (the “ACMPR Application“).

The acquisition of CannMart represents a strategic decision for Namaste to leverage its strength in e-commerce and logistics in becoming a leader in retail distribution of medical cannabis in Canada. The rationale for the acquisition includes but is not limited to:

  • Expansion of Namaste’s product offerings, with the ability to sell both vaporizers and consumables from one location. Namaste aims to be a one-stop-shop for medical cannabis consumers in Canada.
  • Namaste’s ability to market and brand medical cannabis products to its 50,000+ dataset of Canadian consumers.
  • Namaste launching a Canadian warehouse in the CannMart facility in order to process both vaporizer and medical cannabis shipments, medical cannabis packaging, filling for pod-based vaporizers, and distribution for other brands of medical cannabis products.
  • Namaste’s ability to provide same day delivery within the Greater Toronto Area and next day delivery within Canada.

CannMart’s ACMPR Application

CannMart’s ACMPR Application and proposed business model are unique in the industry, as CannMart has applied only to sell, and not produce, medical cannabis. Under this model and subject to obtaining a licence from Health Canada, CannMart would have the ability to purchase wholesale medical cannabis from other licensed producers and sell to individual patients in accordance with the ACMPR.

The ACMPR Application has completed the “security clearance” stage and is currently in the “review” stage of the licensing process. CannMart’s proposed facility is a 4,000 sq. ft. industrial building located in Etobicoke, Ontario (the “Facility“). Pursuant to the Agreement, the Company will assume all of the going forward liabilities and obligations of CannMart, including the remaining build-out costs needed to prepare the Facility for the final stages of the licensing process and the pre-licensing inspection.

Terms of the Agreement

The terms of the Agreement are as follows:

  • Valuation of CannMart at $3.55M CAD;
  • $50,000 CAD in cash to the vendors was paid on April 6, 2017;
  • $2,500,000 CAD worth of Namaste common shares will be issued to the vendors on closing; and
  • $1,000,000 CAD worth of Namaste common shares will be issued to the vendors upon certain milestones.

The common shares of Namaste issued in connection with any milestones will be issued at a price of $0.2884 per Namaste common share.

Closing of the transaction is anticipated to be on or about April 28, 2017.

In connection with the transaction, Clarus Securities Inc. provided advisory services to Namaste and received consideration of $10,000 in cash and will receive 1,040,222 common shares of Namaste upon satisfaction of the milestones outlined in the Agreement.

Conference Call

Namaste will be holding a conference call at 8:30 AM on Tuesday April 25th to discuss and answer questions regarding the acquisition of CannMart and other business items. The call will be led by Namaste’s CEO Sean Dollinger and CFO Philip van den Berg.

NOTE: In order to join this conference call:

  • Participant toll free dial in number: 844-862-1432.
  • Enter EVENT PASSCODE 7865624.

Management Commentary

Mr. Sean Dollinger, President and CEO of Namaste, comments: “We are very excited to announce our signing of the definitive agreement with CannMart. This acquisition will open the door for Namaste to use our expertise with e-commerce and online marketing in order to sell medical cannabis through our existing platform and to our Canadian customers. We see this as a great vertical for Namaste, not only to retail medical cannabis online, but to also utilize our strength in logistics and shipping to offer a one-stop-shop for all medical cannabis related products in Canada. Our facility will be equipped for distribution, as well as packaging for other medical cannabis products. We see this acquisition as the start of Namaste’s effort to expand in consumables sales, not only in Canada but also in other regions in which Namaste operates.”

Option Grant

On March 29, 2017, the Company granted 2,850,000 stock options to employees, contractors and consultants of the Company. The options have an exercise price of $0.26 per share for a term of five years.

About Namaste Technologies Inc.

Namaste Technologies Inc. is an emerging leader in vaporizer and accessories space. Namaste has 26 e-commerce retail stores in 20 countries, offers the largest range of brand name vaporizers products on the market, and is actively manufacturing and launching multiple unique proprietary products for retail and wholesale distribution. The Company is currently focused on expanding its product offering, acquisitions and strategic partnerships, and entering new markets globally.

On behalf of the Board of Directors

Sean Dollinger, Chief Executive Officer

Further information on the Company and its products can be accessed through the links below:

www.namastetechnologies.com

www.namastevaporizers.com

www.namastevaporizers.co.uk

www.vaporseller.com

www.everyonedoesit.com

www.everyonedoesit.co.uk

FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

Namaste Technologies Inc.
Sean Dollinger
Chief Executive Officer
+1 (786) 389 9771
info@namastevapes.com
www.namastetechnologies.com

AGORACOM Welcomes Back American Creek Resources $AMK.ca

Posted by AGORACOM-JC at 9:24 AM on Friday, April 21st, 2017

AMK: TSX-V, OTCBB: ACKRF

RECENT HIGHLIGHTS

  • Tudor Has Discovered a New Gold Zone at Treaty Creek: 110 M of 0.909 g/t Gold, Upper 316 M of Hole Yet to Be Assayed
  • Specimens from the Electrum property average 27,092 gm/tonne silver and 248 gm/tonne gold. Read More
  • Tudor has now completed the previously announced Magnetotelluric survey and has commenced drilling Read More
  • Hole CB-16-03 returned 0.526 g/t gold over 629.7 meters
  • Included within this wide 629.7 meter interval is 338 meters of 0.70 g/t gold
  • Also included 54 meters (from 88 to 142 meters) of 1.117 g/t gold and 122 meters of 0.965 g/t gold

WHY AMERICAN CREEK RESOURCES?

  • American Creek has exceptional precious metal properties throughout British Columbia including two of the most prospective projects found in B.C.’s Golden Triangle; the Electrum and Treaty Creek properties.
  • The Electrum property is geologically similar to the nearby Brucejack (going into production in 2017) and the nearby Premier Mine (past producer).
  • So far over 130 million ounces of gold, 800 million ounces of silver and 20 billion pounds of copper (all categories included), representing one of the greatest concentrations of metal value on the planet, have been delineated within the geological system shared by KSM, Brucejack, and Treaty Creek.

Agoracom Aug 3

EXCEPTIONAL PROPERTIES

 

The Electrum is located in British Columbia’s prolific Golden Triangle; one of the richest areas of mineralization in the world with one new mine having come online in 2015 (Imperial Mines Red Chris) and another scheduled for 2017 (Pretium Brucejack) and at least three more world-class mining projects headed toward production.

The property has a rich history with some of the highest grade hand-mined ore mined in North America (1,661 g/t Au with 2,596 Ag)combined with excellent logistics. The property is located directly between two high-grade veining gold/silver mines; the past producing Silbak Premier mine and Pretiums high-grade Brucejack mine (production in 2017). All three lie within the Iskut mineral district (a particularly prolific part of the Canadian Cordillera) with numerous geological similarities between them.

On May 11th 2016 American Creek formed a joint venture agreement with Tudor Gold wherein American Creek retains 40% of the property.Tudor Gold will be the operator while both companies will work together to develop the property.This partnership is very beneficial for American Creek as its flagship project will be able to advance at a much greater pace due to the geological expertise, experience, resources, management, and exposure that Tudor Gold brings to the table.

The Electrum Property holds significant potential which led to a JV agreement with Tudor Goldwhen considering its high-grade nature combined with the exceptional logistics in place.

  • Located in the prolific Golden Triangle of northwestern British Columbia, an area encompassing mineral rich belts that host more than 43 past producing mines including Eskay Creek, Silbak Premier, Granduc and Big Missouri. It is a hotbed of activity with one new mine having come online in 2015 (Imperial Mines Red Chris) and another scheduled for 2017 (Pretium Brucejack) and at least three more world-class mining projects headed toward production.
  • Located in a particularly rich valley with 4 past producing commercial mines and a 5th in the adjacent valley.
  • Includes the historic East Gold Mine that had intermittent small-scale production of approximately 46 tonnes of ore with grades averaging 1,661 grams of gold per tonne and 2,596 grams of silver per tonne (roughly 50oz gold with 75oz silver).
  • Mineralization is believed to be very similar to the silver-gold-base metal veins responsible for the precious metal mineralization found in the Silbak Premier Mine and the Big Missouri mines (located in same extended valley).
  • Pretiums Brucejack Summary Report (for exploration) compares itself geologically to the Silbak Premier mine.
  • Electrums Summary Report (for exploration) compares itself geologically to the Silbak Premier mine.
  • High-grade mineralization at surface has been confirmed extending over a 500 x 500m area. Specimens across that area include numerous bonanza grade results including 1,926 g/t gold with 37,995 g/t silver, 80.96 g/t gold with 80,818 g/t silver, 694 g/t gold with 550 g/t silver, 54.77 g/t gold with 14,903 g/t silver, 615 g/t gold with 616 g/t silver, 395 g/t gold with 46,601 g/t silver, and many more.
  • Drilling showed a continuation of high grade intervals at depth including grades up to 440 g/t gold with 400 g/t silver over 0.52m. Other high grade gold intervals include 38.4 g/t over 0.45m, 31.4 g/t over 2m, 29.9 g/t over 2m,16.9 g/t over 1.5m, 16.7 g/t over 1.3m, and 12.3 g/t over 1.9m along with longer intervals of 3 g/t over 26m, 1 g/t over 50m, and 0.5 g/t over 31m. High grade silver intervals at depth including 583g/t over 0.3m, 420 g/t over 0.9m, 384 g/t over 0.7m and 374 g/t over 0.65m were also discovered.
  • A very successful small program was run in the fall of 2015 wherein:
    o A new approach focusing on high-grade was employed
    o New zones of gold / silver mineralization were discovered with drill intersections grading from one up to 14 grams of gold per tonne.
    o A better understanding of the high-grade veining system was obtained
    o Numerous outcrops were tested on surface. 24 specimens were taken from the Shiny Cliff and averaged 248 g/t gold with 27,092 g/t silver, the highest sample being 1,926 g/t gold with 37,955 g/t silver. Specimens taken from a boulder 20m down slope from the Shiny Cliff averaged 10 g/t gold with 857 g/t silver.
    o Eleven specimens were collected along a quartz vein at the Rico showing. The specimens from the structure averaged 54 g/t gold with 11,512 g/t silver, the highest sample being 270 g/t gold with 44,048 g/t silver. Thirteen specimens were collected from a vein on Mine Hill and averaged 6 g/t gold with 522 g/t silver.
    o The program proved the Electrum Property has multiple high-grade gold-silver epithermal breccia vein systems and gave us a better understating of their sequencing.
  • Excellent logistics including road access, power located 2 km away and bulk tonnage shipping ports and supportive mining town located just40 km away in a mining friendly jurisdiction.

For a short video on the Electrum property; click here.

For a presentation on the 2015 drill program; click here.

Treaty Creek Property

Treaty Creek is located in British Columbia’s prolific Golden Triangle; one of the richest areas of mineralization in the world with one new mine having come online in 2015 (Imperial Mines Red Chris) and another scheduled for 2017 (Pretium Brucejack) and at least three more world-class mining projects headed toward production.

On May 11th 2016 American Creek formed a joint venture agreement with Tudor Gold wherein American Creek retains a carried interest of 20% of the property until a production notice is given. A partner with the expertise, backing, management team, and experience to develop this potential world scale project was sought after by AMK. Tudor Gold meets and exceeds all of those requirements needed to fully realize the potential of Treaty Creek. American Creek will not have to raise money or dilute as development takes place.

Mineralization in the Treaty Creek claims area lies within the same broad hydrothermal system that generated the several deposits on the Seabridge Gold KSM and the Pretivm Brucejack properties that lie immediately southwest of the Treaty Creek claims. So far over 130 million ounces of gold, 800 million ounces of silver and 20 billion pounds of copper (all categories included), representing one of the greatest concentrations of metal value on the planet, have been delineated within the geological system shared by KSM, Brucejack, and Treaty Creek.

Seabridge Gold’s KSM is the world’s largest undeveloped gold/silver project by reserves while Pretium’s Brucejack is the highest grading undeveloped large-scale gold project in the world. KSM has just past the environmental and permitting stage while the Brucejack is in construction phase. Treaty Creek is part of the same large hydrothermal system as it’s neighbours, hosts the same bedrock geology as its neighbours, the same magneto-telluric (MT) anomalies that proved to be large deposits on both Seabridge and Pretivm’s claims, the same major fault system (Sulphurets) that is responsible for KSM’s deposits, and initial exploration and drilling show similar results to initial drilling on KSM.

A recent Government geological report shows Treaty to be “in the right neighbourhood for B.C’s next big deposit”.Treaty meets all three main criteria of the report which states “that is a big game changer for explorers in the region, because it will get them closer to making a discovery”.

The geological markers on Treaty Creek are saying there are great similarities to the KSM / Brucejack / Valley of the Kings and other deposits found within the same hydrothermal system.Now the right partnership is in place to advance the project and realize its potential.

For a 2 minute video on Treaty Creek; click here.

For an in-depth geological video on Treaty Creek; click here.

Gold Hill Property

The Gold Hill property is located in Southern British Columbia near Cranbrook.Logistics are exceptional with forestry roads throughout the property and power nearby. Gold on the Wild Horse River was discovered in the fall of 1863 by American prospectors and one of the West’s greatest gold rushes ensued. The Wild Horse River yielded close to $7,000,000 dollars (48 tonnes of gold or around $2 Billion in today’s dollars). It is believed that a far greater amount was mined and never accounted for.

The river is considered to be one of the greatest gold creeks in the entire province of British Columbia. The majority of the gold taken from the river was located along a 6km stretch between Boulder Creek (upstream) and Brewery Creek (downstream). While most of the gold has been taken from the placer deposits downstream from Gold Hill, there are still placer operations in the area ranging from small scale panning / sluicing to full scale mining operations.

Historic efforts were made to trace the source / sources of the placer gold. This led explorers (including geologists from Cominco) up the Boulder Creek to what is now called the Gold Hill property. This property constitutes a significant portion of the watershed for Boulder Creek including two main areas where gold was recovered by Cominco (along with others). These areas are known as Big Chief and Gold Hill. Both areas are believed to be major contributing sources for the incredible resources found in the Wild Horse River and as such have tremendous potential. While gold was discovered on the property, the gold price in 1900 did not support extensive hard rock exploration at the time.

The property has been overlook and sat dormant for many years. American Creek was very fortunate to acquire a property with such a rich history and such huge potential. The property was acquired in 2015 and hard rock exploration will begin in 2016.

Namaste Signs Services Agreement with Canopy Growth Corporation $N.ca

Posted by AGORACOM-JC at 9:01 AM on Thursday, April 20th, 2017

Nlogo

  • building on a previously announced MOU, the Company has entered into a services agreement with Canopy Growth Corporation
  • Namaste’s database consists of approximately 300,000 customers that generate upwards of 600,000 site visits monthly
  • Approximately 28,000 of these monthly site visits are generated from customers residing in Canada

VANCOUVER, BRITISH COLUMBIA–(April 20, 2017) - Namaste Technologies Inc. (“Namaste” or the “Company“) (CSE:N)(CSE:N.CN)(FRANKFURT:M5BQ)(OTCQB:NXTTF) is pleased to announce that, building on a previously announced MOU, the Company has entered into a services agreement (the “Agreement“) with Canopy Growth Corporation (“Canopy“). This Agreement represents the execution of Namaste’s strategic objective to actively migrate medical cannabis consumers to a licensed producer. Namaste’s database consists of approximately 300,000 customers that generate upwards of 600,000 site visits monthly. Approximately 28,000 of these monthly site visits are generated from customers residing in Canada.

The purpose of the Agreement is to outline the responsibilities of each of Namaste and Canopy with respect to the provision of education and awareness regarding safe and legal access to medical cannabis. Namaste’s responsibilities include, but not are limited to: providing information on its websites and blogs outlining how to obtain medical cannabis from legal licensed producers including details on what is legally required under the Access to Cannabis for Medical Purposes Regulations.

Management Commentary

Sean Dollinger, President and CEO of Namaste, comments: “Our Company has successfully built one of the largest and most global client relationship databases in the cannabis industry and we view broadening our strategic alliances to the benefit of our customers and shareholders. Consistent with our strategy to partner with leading companies that hold themselves to the highest standards, Canopy represents the ideal partner for us to roll-out this strategy alongside. Going forward, we see multiple opportunities to expand this strategy globally.”

About Namaste Technologies Inc.

Namaste Technologies Inc. is an emerging leader in vaporizer and accessories space. Namaste has 26 e-commerce retail stores in 20 countries, offers the largest range of brand name vaporizers products on the market and is actively manufacturing and launching multiple unique proprietary products for retail and wholesale distribution. The Company is currently focused on expanding its product offering, acquisitions and strategic partnerships, and entering new markets globally.

On behalf of the Board of Directors

Sean Dollinger, Chief Executive Officer

Further information on the company and its products can be accessed through the link below:

FORWARD LOOKING INFORMATION

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions. Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to several factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

Namaste Technologies Inc.
Sean Dollinger
Chief Executive Officer
Direct: +1 (786) 389 9771
info@namastevapes.com

INTERVIEW: betterU (BTRU:TSX-V) $30 Million Marketing Plan Reaches 100 Million Potential Customers Every Week $BTRU.ca

Posted by AGORACOM-JC at 8:51 AM on Wednesday, April 19th, 2017

Tetra Bio-Pharma & Aphria Announce Plans for the Joint Distribution of Dried Medical Cannabis in the Maritime Provinces & Quebec $TBP.ca

Posted by AGORACOM-JC at 8:45 AM on Wednesday, April 19th, 2017

Tbp large

  • Announced plans today for the joint distribution of dried medical cannabis in the maritime provinces and Quebec
  • Enter into a joint supply agreement, with Aphria supplying dried medical cannabis under its ACMPR license, and Tetra packaging the product using the manufacturing process developed for its in-progress clinical drug trial for PPP001

OTTAWA, ONTARIO–(April 19, 2017) - Tetra Bio-Pharma Inc. (“Tetra”) (CSE:TBP)(CSE:TBP.CN)(OTCQB:GRPOF) and Aphria Inc. (“Aphria”) (TSX:APH) (OTCQB:APHQF), announced plans today for the joint distribution of dried medical cannabis in the maritime provinces and Quebec.

Tetra and Aphria will enter into a joint supply agreement, with Aphria supplying dried medical cannabis under its ACMPR license, and Tetra packaging the product using the manufacturing process developed for its in-progress clinical drug trial for PPP001. The formulation and packaging will be completed by Tetra, under its CDSA dealer’s licence, at its New Brunswick facility. Based on the success of the venture, Tetra and Aphria may expand into other provinces. The venture is preparing to initiate its commercial operations early summer 2017 with revenues commencing in Tetra’s third quarter of 2017 and Aphria’s first quarter of 2018.

“This commercial venture is an important decision for Tetra shareholders as it will start generating revenues this summer which will be invested back into developing PPP001 as a prescription pharmaceutical,” said Andre Rancourt, CEO of Tetra Bio-Pharma Inc. “Tetra will be accelerating its manufacturing and quality studies as required by the U.S. and Canadian prescription drug and controlled substance regulations. The investment in this research will be offset by sales revenues generated under the ACMPR.”

“The commercial venture between Tetra and Aphria will enhance Aphria’s brand visibility and distribution of our high-quality medical grade cannabis into the maritime provinces and Quebec, as we look to meet the commercial demand for PPP001,” said Vic Neufeld, CEO of Aphria Inc. “As a leading Canadian licensed producer, it was important for us to work with an organization that shares our focus on pharmaceutical-grade quality assurance and control. Tetra’s emphasis on developing products driven by patient needs and scientific research and development makes them the perfect partner in this important next step for Aphria.”

Tetra and Aphria have invested in the development of its PPP001 drug and will continue to invest to bring PPP001 to market in both Canada and USA as the first prescription drug using dried cannabis. The corporations have developed a high quality dried cannabis product and would like to make it available to physicians under the current ACMPR program. The quality and clinical research studies completed to date would be integrated into a joint Continuing Medical Education program for physicians and pharmacists. Tetra and Aphria have concluded that there is demand for an evidence-based approach in medical cannabis and the two companies intend on using their pharmaceutical approach to help patients. The venture will also be commercializing devices for the inhalation of medical cannabis.

About Tetra Bio-Pharma:

Tetra Bio-Pharma is a multi subsidiary publicly traded company (CSE:TBP)(CSE:TBP.CN)(OTCQB:GRPOF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

About Aphria:

Aphria Inc., one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. We are the first public licenced producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters. For more information, visit www.Aphria.com.

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements – Tetra Bio-Pharma Inc.

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Forward-looking statements – Aphria Inc.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS – APHRIA: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements with respect to internal expectations, estimated margins, expectations related to the completion of this project, its revenue and gross margin expectations, expectations for future growing capacity and costs, the completion of any capital project or expansions, any commentary related to the legalization of marijuana and the timing related thereto, expectations of Health Canada approvals and expectations with respect to future production costs. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical marijuana industry in Canada generally, income tax and regulatory matters; the ability of Aphria to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Tetra Bio-Pharma Inc.
Edward Miller
Vice President, IR & Corporate Communications
edward@tetrabiopharma.com
(343) 689-0714

Aphria Inc.
Nina Godard
Edelman
nina.godard@edelman.com
416-455-6324

Aphria Inc.
Vic Neufeld
President & CEO
1-844-427-4742

Durango Completes Acquisition of Windfall Lake $DGO.ca

Posted by AGORACOM-JC at 8:25 AM on Tuesday, April 18th, 2017

Logo

  • Windfall Lake Gold Camp area (the “Windfall East Property” and “Windfall West Property”, and collectively the “New Windfall Properties”) has been approved by the TSX Venture Exchange.
  • Durango closed the acquisition on April 11, 2017

Vancouver, BC / April 18, 2017 – Durango Resources Inc. (TSX.V-DGO) (Frankfurt-86A1) (OTC-ATOXF), (the “Company” or “Durango”) announces that further to its news release dated March 6, 2017, its recent acquisition of properties in the Windfall Lake Gold Camp area (the “Windfall East Property” and “Windfall West Property”, and collectively the “New Windfall Properties”) has been approved by the TSX Venture Exchange. Durango closed the acquisition on April 11, 2017.

The New Windfall Properties are comprised of approximately 2,700 hectares and adjoin the limit of Osisko Mining Inc.’s (TSX-OSK) property. The Windfall East Property is approximately five kilometres southeast of the Black Dog Au-Ag-Cu discovery. Osisko is currently drilling the extent of this new mineralization which appears as distinct subvertical zones dipping to the southeast and distributed along a NE-trending linear magnetic structure (Osisko’s Press release of January 18, 2017 and conceptual model on Osisko’s website).

The Windfall East Property runs along the southern perimeter of a projected large fault/lineament, a favorable environment for Archean lode gold deposit. Although the Windfall East Property is located outside the mapped Urban Barry greenstone belt, it remains prospective as many gold occurrences are found outside greenstone belts (eg. Cheechoo Project of Sirios Resources) and are rather driven by structural controls.

A limited amount of exploration work has been conducted over the Windfall East Property which totals an area of over 2,000 hectares. It is located within 1.5 km of the regional northeast-southwest faults extending from the Gladiator project of Bonterra Resources. A power line is crossing the central portion of the east claim block, and several lakes and rivers are present, which may facilitate access for future exploration work. Topography indicates that the area could be suitable for a till survey, as a first step to outline future targets.

The Windfall West Property is an additional block of approximately 675 hectares and is located to the west of Durango’s Trove property and adjoins Beaufield Resources Inc.’s (TSX.V-BFD) western perimeter and is accessible for exploration work via a main logging road from the town of Lebel-sur-Quevillon.

Marcy Kiesman CEO of Durango stated, “Durango is reviewing several exploration programs which could be initiated to advance the New Windfall Properties. Durango is confident in the prospective gold acquisitions in the Windfall area and looks forward to the exploration year ahead.”

The technical contents of this release were approved by Mrs. Isabelle Robillard, M.Sc., P.Geo., an associate of Inlandsis Consultants s.e.n.c who is a Qualified Person as defined by National Instrument 43-101.

About Durango

Durango is a natural resources company engaged in the acquisition and exploration of mineral properties. The Company has a 100% interest in the Mayner’s Fortune and Smith Island limestone properties in northwest British Columbia, the Decouverte and Trove gold properties in the Abitibi Region of Quebec, and the NMX East lithium property near the Whabouchi mine and the Buckshot graphite property near the Miller Mine in Quebec, the Whitney Northwest property near the Lake Shore Gold and Goldcorp joint venture in Ontario.

For further information on Durango, please refer to its SEDAR profile at www.sedar.com.

Marcy Kiesman, Chief Executive Officer

Telephone: 604.428.2900 or 604.339.2243

Facsimile: 888.266.3983

Email: durangoresourcesinc@gmail.com

Website: www.durangoresourcesinc.com

Forward-Looking Statements

This document may contain or refer to forward-looking information based on current expectations, including, but not limited to the exploration of the New Windfall Properties, the entering into of any transaction and/or financing with any third parties and the impact on the Company of these events. Forward-looking information is subject to significant risks and uncertainties, as actual results may differ materially from forecasted results. Forward-looking information is provided as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances. For a detailed list of risks and uncertainties relating to Durango, please refer to the Company’s prospectus filed on its SEDAR profile at www.sedar.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Mining Minute – 2.12- Infrastructure Funds Application Submitted Yet? $KWG.ca

Posted by AGORACOM-JC at 5:22 PM on Thursday, April 13th, 2017

The marijuana market could be (and possibly already is) bigger than the market for beer in Canada $TBP.ca $N.ca

Posted by AGORACOM-JC at 5:20 PM on Thursday, April 13th, 2017

The marijuana market could be (and possibly already is) bigger than the market for beer in Canada

Pot’s retail therapy

TORONTO — It’s a hot, sunny Thursday afternoon on the hard edge of Queen Street West, and the foot traffic at Eden, a pot dispensary, is brisk.

Retailers along this strip of trendy clothing stores, bars, restaurants, shoe shops, tattoo parlours, hairstylists, comic stores and coffee joints cater to the urban hip, and Eden is no different. lnside, iceberg-blue lights illuminate jewel-case cabinets with the product — glass vials of Hindu Kush, El Hefe, Organic Blue Dream — artfully displayed.

On the aquamarine-blue wall at the front are two white iPads, for customers who need quick access to the Internet to check product information.

The place is spotless, sharp. And the air is heavy with the unmistakeable sweet smell of cannabis.

Pot store
The fridge at Eden Medicinal Society, a cannabis retailer in Toronto. (Tyler Anderson / National Post)

Behind the counter, two clerks, a man and a woman both in their 20s, both dressed like their customers, are filling orders, taking cash.

The average transaction, those in the business say, is $50. A pre-rolled joint is $12, but Alicia, the manager, says they won’t start selling a lot of those until the evening, when the university crowd and the kids from the suburbs come downtown.

The afternoonwalk-ins are largely cannabis users who rely on the flowers, ointments, teas, and oils to ease some chronic ailment, or they are creative types — writers, graphics artists, filmmakers — who find extra insight and energy through cannabinoid stimulation. They all have prescriptions from a licensed physician.

The product mix and retail approach at Eden’s downtown store is different than what you will find at the company’s newest outlet a few blocks north near Bayview and Eglinton. There are more seniors and aging baby boomers in that neighbourhood so the store opens earlier and closes earlier.

The Eden outlets are among the 100 or so pot dispensaries in Toronto, but there is easily demand, those in the industry say, for 1,000 such businesses.

They are owned and operated by a mix of campaigners and capitalists.


The campaigners have been working for years to legalize marijuana use. They believe in the huge potential for the drug to manage pain, ease anxiety, and help many to a more productive, happy, creative and healthy existence.

Tania Cyalume and Brandy Zurborg opened their storefront dispensary, Queens of Cannabis, on Bloor Street West just north of Little Italy in February.

Queens of Cannabis owners Tania Cyalume and Brandy Zurborg outside their shop in May 2016. (Maryam Shah / Postmedia Network)

“I guess when you believe in a product, you really believe in it because you’ve seen the way that it affects people,” said Cyalume.

The products Cyalume and Zurborg sell and their approach to retailing match their personal philosophies and lifestyles. Both are vegans, and the edible cannabis products they stock are vegan and  pesticide-free.

Their crusade is about serving patients because they are patients themselves, and use cannabis products regularly to treat their own chronic pain and ailments.

“We’re patients and we believe in it. We also believe that patients have the first right to access before recreational. There is only so much supply, and there is a huge demand,” said Zurborg, who trained as a certified management accountant designation and was  an auditor with the Canada Revenue Agency.

Their goal is not necessarily to get rich. They speak of one day being able to use the proceeds of their retail operation to help fund outreach, at hospices for example, where they can spread the word about the life-changing value of cannabis products.

Marina, who preferred her last name not be used, is a capitalist. She and her husband have had as many as seven dispensaries, some through a franchise model they were trying to build. When she got into the business a few years ago, she approached with a capitalist’s zeal and eye for profit.

The woman has agreed to talk about her industry at an upscale diner set among the forest of steel-and-glass condominium towers where Lake Ontario meets the Toronto suburb of Etobicoke. She arrived in a gleaming white SUV. Petite, direct and energetic, Marina makes no bones about the fact she got into the business to make a pile of cash.

- See more at: http://news.nationalpost.com/features/o-cannabis-retail-therapy#sthash.q9qC3FZy.dpuf

AGORACOM Welcomes BetterU Education Corp. (TSX-V:BTRU) with $30M marketing investment deal signed, ability to reach 100M potential learners each week $BTRU.ca

Posted by AGORACOM-JC at 4:50 PM on Wednesday, April 12th, 2017

Betteru large

CONNECTING GLOBAL EDUCATION WITH THE INDIAN MARKETPLACE

WHY BETTERU EDUCATION?

  • Partnering with leading content providers from around the world
  • Promoting / managing quality online education in India
  • Marketplace’ has been designed to represent our educators programs

TIMES OF INDIA PARTNERSHIP

  • betterU signed a 150 Crore (approx $30 million) marketing investment deal with Bennett Coleman Company Ltd. (Times Group)
  • Provides betterU with significant market visibility
  • Enables betterU to be promoted across upwards of 80% of the country by means of newsprint, radio, digital, TV, OHH and Medianet
  • Bringing awareness to marketplace, education partners’ programs to the mass population of the country on a weekly basis.

THE MODEL

  • Provides mass marketing across India (Newsprint, Radio, TV, Digital, and Magazine),
  • Collects all registrations and payments, then through back end coding, connect the learner to the content partner’s course
  • Holds back 20% to 50% of revenues collected as their fee

WHY INDIA

  • Indian Government has mandated to educate and skill up 500 million people by 2022
  • Focused on digitizing the country
  • National Skills Development Corporation has a directive to educate and skill up 150 million people in India
  • Online education is the only way these mandates can be accomplished
  • India is expecting to double in online education sales from $20B to $40B this year.

Investment Highlights

Market: Access to ‘high-barrier to entry’ Indian market through current Indian operations.

First Mover: Potential to become leading “global education marketplace” in India.

Developed Product: GENERATING REVENUE!

Unmatched Variety: Over 6,500 courses available.

Wide Audience: K-12, exam preparation, skills development, higher-ed and more.

Product Expansion Opportunities: B2B, B2C learning and employment solutions.

INFRUSTRUCTURE 

  • Established an Indian entity in order to effectively do business in India
  • Ability to collect from 200 different payment methods in India
  • People on the ground in India
  • Established strong relationships with institutions, training partners and leaders across multiple sectors.

STOCK CHART

Tetra Bio-Pharma Announces Opening of a New Brunswick Office for Manufacturing & Sales Activities $TBP.ca

Posted by AGORACOM-JC at 4:46 PM on Wednesday, April 12th, 2017

Tbp large

  • Announced today it has opened an office in Moncton, New Brunswick for its manufacturing and sales activities
  • New Brunswick becoming the hub for the Canadian Cannabis industry

OTTAWA, ONTARIO–(April 12, 2017) - Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(CSE:TBP.CN)(OTCQB:GRPOF) announced today it has opened an office in Moncton, New Brunswick for its manufacturing and sales activities. New Brunswick is becoming the hub for the Canadian Cannabis industry.

Tetra is preparing to commercialize several retail products later this year with expected revenues to be generated for the corporation in the fourth quarter. Tetra has already initiated the process to manufacture the first products that act on the cannabinoid system that will be commercialized later this year for sale in Canada and the USA. The Company also intends on commercializing devices (e.g., pipes) for the consumption of medical marijuana in 2017. The Tetra office in Moncton will be responsible to oversee the timely production and launch of the products as well as adhering to the corporation’s budgets.

Tetra has initiated its Phase I clinical trial in March 2017 after manufacturing the PPP001 cannabis drug product at the Ford Pharma contract manufacturing facility in Moncton, New Brunswick. This contract facility developed the proprietary process and equipment required to produce PPP001 pellets and packaging operations. Tetra is also using the contract services of RPC, a New Brunswick provincial crown corporation, to perform its quality control studies to assure that PPP001 conforms to its drug product specifications and quality requirements of a prescription drug.

“We are pleased to announce the opening of a new office in New Brunswick which has become one of the leading provinces in Canada to support the cannabis industry,” said Andre Rancourt, CEO of Tetra Bio-Pharma Inc. “Tetra will manufacture our PPP001 prescription drug as well as additional scheduled products later this year. We are advancing our projects forward which are on time and on budget, a key priority for the Tetra team. We are now one-step closer towards our goal of commercialization in bringing our innovative cannabis based products to market.”

“We acted quickly to prepare for the development of this industry in New Brunswick,” said Stephen Lund, CEO of Opportunities NB. “The addition of Tetra Bio-Pharma to the province is welcomed news. We have the research, education and production facilities in place for companies to be successful in this rapidly growing industry.”

According to Dr. Guy Chamberland, CSO at Tetra Bio-Pharma Inc., “The use of the facility in Moncton allows Tetra to manufacture the PPP001 drug product for the clinical trial according to the corporation’s timelines and budget. The RPC research and technology organization provides Tetra with the high-level expertise required for assessing the quality aspects of PPP001 while keeping the costs associated with these activities within budget due to RPC not-for-profit status. I can report that the Phase 1 trial is advancing on schedule and according to the corporation’s plans we expect to complete the Phase Ia portion of the study by mid-May. The results of the Phase Ia will provide TBP with a strategic understanding of the commercial potential of marijuana products and allow the corporation to complete its Phase II and III trial plans.”

About Tetra Bio Pharma:
Tetra Bio Pharma is a multi subsidiary publicly traded company (CSE:TBP)(CSE:TBP.CN)(OTCQX:GRPOF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Edward Miller
Vice President, IR & Corporate Communications
edward@tetrabiopharma.com
(343) 689-0714